An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)
Clinical trial NCT02268552 · COMPLETED
Trial details
- NCT number
- NCT02268552
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-02
- Primary completion
- 2022-12-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.